Oncology
1 drug is in development for Ovarian Carcinoma.
- Companies
- 1
- Clinical trials
- 21
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Ovarian Carcinoma pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| STRO-002 | SUTRO BIOPHARMA, INC. (STRO) |
About this indication
Ovarian Carcinoma context
Oncology·MeSH: Ovarian Neoplasms (D010051)
Narrower concept of MeSH descriptor Ovarian Neoplasms
Frequently asked questions
How many drugs are in development for Ovarian Carcinoma?
BioSniper tracks 1 drug in development for Ovarian Carcinoma across 1 company.
How many clinical trials target Ovarian Carcinoma?
There are 21 clinical trials targeting Ovarian Carcinoma tracked by BioSniper.